Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for interest income |
45,000
EUR
|
40,000
EUR
|
| Adjustments for dividend income |
-
EUR
|
-
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
4,708,000
EUR
|
1,031,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
5,521,000
EUR
|
4,140,000
EUR
|
| Adjustments for decrease (increase) in biological assets |
11,990,000
EUR
|
1,529,000
EUR
|
| Adjustments for amortisation expense |
24,000
EUR
|
16,000
EUR
|
| Adjustments for depreciation expense |
6,443,000
EUR
|
6,661,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
189,000
EUR
|
202,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, inventories |
17,000
EUR
|
2,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, property, plant and equipment |
-
EUR
|
393,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
8,960,000
EUR
|
2,701,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Proceeds from issue of bonds, notes and debentures |
5,880,000
EUR
|
6,000,000
EUR
|